nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—HTR2C—metabolic syndrome X	0.813	1	CbGaD
Methotrimeprazine—HTR2A—arteriole—metabolic syndrome X	0.00456	0.2	CbGeAlD
Methotrimeprazine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00291	0.127	CbGeAlD
Methotrimeprazine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00195	0.0857	CbGeAlD
Methotrimeprazine—HTR2A—artery—metabolic syndrome X	0.00111	0.0486	CbGeAlD
Methotrimeprazine—ADRA1B—kidney—metabolic syndrome X	0.00104	0.0455	CbGeAlD
Methotrimeprazine—HTR2A—endothelium—metabolic syndrome X	0.000936	0.041	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2C—metabolic syndrome X	0.000917	0.122	CrCbGaD
Methotrimeprazine—HTR2A—blood vessel—metabolic syndrome X	0.000863	0.0378	CbGeAlD
Methotrimeprazine—CHRM2—cardiovascular system—metabolic syndrome X	0.000797	0.0349	CbGeAlD
Methotrimeprazine—CHRM1—cardiovascular system—metabolic syndrome X	0.000725	0.0318	CbGeAlD
Methotrimeprazine—CHRM3—kidney—metabolic syndrome X	0.000635	0.0278	CbGeAlD
Methotrimeprazine—ADRA1A—cardiovascular system—metabolic syndrome X	0.000596	0.0261	CbGeAlD
Methotrimeprazine—CHRM3—adipose tissue—metabolic syndrome X	0.000572	0.0251	CbGeAlD
Methotrimeprazine—Mesoridazine—HTR2C—metabolic syndrome X	0.000559	0.0743	CrCbGaD
Methotrimeprazine—ADRA2C—kidney—metabolic syndrome X	0.000555	0.0243	CbGeAlD
Methotrimeprazine—Prochlorperazine—HTR2C—metabolic syndrome X	0.000541	0.0719	CrCbGaD
Methotrimeprazine—ADRA1A—adipose tissue—metabolic syndrome X	0.000525	0.023	CbGeAlD
Methotrimeprazine—ADRA2C—adipose tissue—metabolic syndrome X	0.000501	0.0219	CbGeAlD
Methotrimeprazine—Fluphenazine—HTR2C—metabolic syndrome X	0.000489	0.065	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2C—metabolic syndrome X	0.000471	0.0626	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2C—metabolic syndrome X	0.000448	0.0595	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2C—metabolic syndrome X	0.000446	0.0592	CrCbGaD
Methotrimeprazine—CYP2E1—cardiovascular system—metabolic syndrome X	0.000443	0.0194	CbGeAlD
Methotrimeprazine—CYP2E1—kidney—metabolic syndrome X	0.000434	0.019	CbGeAlD
Methotrimeprazine—Thioridazine—HTR2C—metabolic syndrome X	0.000422	0.056	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2C—metabolic syndrome X	0.000412	0.0547	CrCbGaD
Methotrimeprazine—HRH1—adipose tissue—metabolic syndrome X	0.000407	0.0178	CbGeAlD
Methotrimeprazine—ADRA2A—adipose tissue—metabolic syndrome X	0.000399	0.0175	CbGeAlD
Methotrimeprazine—Trifluoperazine—HTR2C—metabolic syndrome X	0.000391	0.052	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2C—metabolic syndrome X	0.000387	0.0514	CrCbGaD
Methotrimeprazine—HTR2A—cardiovascular system—metabolic syndrome X	0.000385	0.0169	CbGeAlD
Methotrimeprazine—HTR2A—kidney—metabolic syndrome X	0.000377	0.0165	CbGeAlD
Methotrimeprazine—ADRA1A—liver—metabolic syndrome X	0.000368	0.0161	CbGeAlD
Methotrimeprazine—ADRA2C—liver—metabolic syndrome X	0.000351	0.0154	CbGeAlD
Methotrimeprazine—Promazine—HTR2C—metabolic syndrome X	0.000349	0.0464	CrCbGaD
Methotrimeprazine—CYP2D6—kidney—metabolic syndrome X	0.000343	0.015	CbGeAlD
Methotrimeprazine—Chlorpromazine—HTR2C—metabolic syndrome X	0.000307	0.0408	CrCbGaD
Methotrimeprazine—Imipramine—HTR2C—metabolic syndrome X	0.000305	0.0406	CrCbGaD
Methotrimeprazine—CYP1A2—liver—metabolic syndrome X	0.000305	0.0134	CbGeAlD
Methotrimeprazine—CYP2E1—liver—metabolic syndrome X	0.000274	0.012	CbGeAlD
Methotrimeprazine—Acepromazine—ALB—metabolic syndrome X	0.000257	0.0341	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—metabolic syndrome X	0.000251	0.0333	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—metabolic syndrome X	0.000247	0.0328	CrCbGaD
Methotrimeprazine—HTR2A—liver—metabolic syndrome X	0.000238	0.0104	CbGeAlD
Methotrimeprazine—CYP2D6—liver—metabolic syndrome X	0.000217	0.00951	CbGeAlD
Methotrimeprazine—Clomipramine—ALB—metabolic syndrome X	0.000195	0.0259	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—metabolic syndrome X	0.000134	0.0178	CrCbGaD
Methotrimeprazine—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.4e-05	8.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.4e-05	8.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	1.4e-05	8.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	1.4e-05	8.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—LEP—metabolic syndrome X	1.39e-05	8.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APOE—metabolic syndrome X	1.39e-05	8.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.39e-05	8.9e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-05	8.88e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—APOA1—metabolic syndrome X	1.39e-05	8.88e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-05	8.86e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.38e-05	8.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.38e-05	8.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	8.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	1.38e-05	8.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	1.38e-05	8.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	8.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.38e-05	8.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.38e-05	8.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	1.36e-05	8.72e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.36e-05	8.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.36e-05	8.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.35e-05	8.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.34e-05	8.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.34e-05	8.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.33e-05	8.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.33e-05	8.51e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.33e-05	8.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.32e-05	8.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.32e-05	8.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.32e-05	8.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—metabolic syndrome X	1.31e-05	8.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.31e-05	8.35e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—ALB—metabolic syndrome X	1.3e-05	8.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	8.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.3e-05	8.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.3e-05	8.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.3e-05	8.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.3e-05	8.3e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.29e-05	8.25e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.28e-05	8.21e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.28e-05	8.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.28e-05	8.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.28e-05	8.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.28e-05	8.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—GPCR downstream signaling—AKT1—metabolic syndrome X	1.27e-05	8.15e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.27e-05	8.15e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.27e-05	8.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	8.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.26e-05	8.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	1.25e-05	8.02e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	8.02e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—NOS3—metabolic syndrome X	1.25e-05	7.98e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	7.97e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.24e-05	7.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	1.24e-05	7.95e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.24e-05	7.95e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.24e-05	7.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.23e-05	7.9e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	1.23e-05	7.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.23e-05	7.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.22e-05	7.83e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PPARG—metabolic syndrome X	1.22e-05	7.82e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.22e-05	7.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.21e-05	7.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.21e-05	7.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.21e-05	7.75e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.21e-05	7.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	1.21e-05	7.73e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	7.68e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.2e-05	7.68e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—INS—metabolic syndrome X	1.2e-05	7.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.2e-05	7.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.2e-05	7.66e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	7.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.2e-05	7.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	1.19e-05	7.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—INS—metabolic syndrome X	1.19e-05	7.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—INS—metabolic syndrome X	1.19e-05	7.61e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.19e-05	7.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	7.55e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.18e-05	7.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.18e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.18e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.18e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—INS—metabolic syndrome X	1.18e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	7.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.17e-05	7.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	7.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	7.49e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	7.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.16e-05	7.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	1.16e-05	7.42e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	7.41e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	1.16e-05	7.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.16e-05	7.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	1.15e-05	7.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	1.15e-05	7.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.14e-05	7.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—metabolic syndrome X	1.14e-05	7.3e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	7.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	1.14e-05	7.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.14e-05	7.27e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.13e-05	7.22e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.12e-05	7.17e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	1.1e-05	7.05e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	7.05e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	7.04e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ALB—metabolic syndrome X	1.1e-05	7.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	7.01e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.09e-05	6.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	6.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.09e-05	6.96e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	1.09e-05	6.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.08e-05	6.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.08e-05	6.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.08e-05	6.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	6.87e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	1.07e-05	6.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	1.06e-05	6.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—metabolic syndrome X	1.06e-05	6.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.06e-05	6.76e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.05e-05	6.74e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	6.73e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—NOS3—metabolic syndrome X	1.05e-05	6.73e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	6.72e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.05e-05	6.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.05e-05	6.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	6.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	1.04e-05	6.68e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	1.04e-05	6.66e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.04e-05	6.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	1.03e-05	6.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	1.03e-05	6.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	1.03e-05	6.57e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1.03e-05	6.56e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	1.02e-05	6.54e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.02e-05	6.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.01e-05	6.46e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.01e-05	6.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1e-05	6.42e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.96e-06	6.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	9.94e-06	6.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.94e-06	6.36e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	9.84e-06	6.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	9.83e-06	6.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	9.82e-06	6.28e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	9.8e-06	6.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	9.78e-06	6.26e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—metabolic syndrome X	9.62e-06	6.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	9.57e-06	6.13e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CD36—metabolic syndrome X	9.56e-06	6.12e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	9.43e-06	6.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	9.37e-06	5.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.24e-06	5.91e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	9.24e-06	5.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	9.17e-06	5.87e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.16e-06	5.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	9.03e-06	5.78e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	9.02e-06	5.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.02e-06	5.77e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	9e-06	5.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.97e-06	5.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.94e-06	5.72e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	8.89e-06	5.69e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.88e-06	5.68e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	8.86e-06	5.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.85e-06	5.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.83e-06	5.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	8.83e-06	5.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	8.8e-06	5.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	8.71e-06	5.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	8.69e-06	5.56e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	8.67e-06	5.55e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AGT—metabolic syndrome X	8.61e-06	5.51e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—INS—metabolic syndrome X	8.51e-06	5.44e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—metabolic syndrome X	8.44e-06	5.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	8.34e-06	5.34e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	8.34e-06	5.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	8.32e-06	5.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.2e-06	5.25e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	8.19e-06	5.24e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	8.17e-06	5.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	8.14e-06	5.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	8.12e-06	5.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	8.08e-06	5.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	8.04e-06	5.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.02e-06	5.13e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	8.01e-06	5.13e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—metabolic syndrome X	7.84e-06	5.02e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.8e-06	4.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.79e-06	4.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	7.73e-06	4.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.67e-06	4.91e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	7.46e-06	4.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.45e-06	4.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	7.41e-06	4.74e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	7.35e-06	4.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	7.23e-06	4.63e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—INS—metabolic syndrome X	7.21e-06	4.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	7.14e-06	4.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	7.07e-06	4.52e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—metabolic syndrome X	7.06e-06	4.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	6.96e-06	4.46e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.96e-06	4.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.96e-06	4.45e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.94e-06	4.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	6.92e-06	4.43e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	6.9e-06	4.41e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	6.83e-06	4.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	6.83e-06	4.37e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.82e-06	4.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.81e-06	4.36e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—metabolic syndrome X	6.61e-06	4.23e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	6.51e-06	4.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	6.48e-06	4.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	6.42e-06	4.11e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	6.42e-06	4.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.33e-06	4.05e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	6.32e-06	4.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	6.29e-06	4.02e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	6.04e-06	3.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	5.87e-06	3.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	5.8e-06	3.71e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	5.78e-06	3.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	5.78e-06	3.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—metabolic syndrome X	5.74e-06	3.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.57e-06	3.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	5.42e-06	3.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	5.33e-06	3.41e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5.33e-06	3.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	5.26e-06	3.37e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	5.24e-06	3.35e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	5.23e-06	3.35e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	5.22e-06	3.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	5.2e-06	3.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	5.15e-06	3.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	5.13e-06	3.28e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.92e-06	3.15e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.84e-06	3.09e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—metabolic syndrome X	4.83e-06	3.09e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.83e-06	3.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	4.81e-06	3.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	4.8e-06	3.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.77e-06	3.05e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	4.75e-06	3.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.74e-06	3.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.4e-06	2.82e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.43e-06	2.19e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.91e-06	1.86e-05	CbGpPWpGaD
